How to Provide Better Access to More Patients

With Bill Bonello, NeoGenomics and Clynt Taylor, Trapelo

Bill Bonello, president of NeoGenomics Informatics, and Clynt Taylor, president of Trapelo Health, discuss challenges in precision medicine and how evidence-based technologies can help deliver more appropriate, value-based care to more patients.
 
As a subtext to the discussion is the recent acquisition of Trapelo Health, creator of clinical decision-making platform Trapelo, by NeoGenomics Informatics, provider of bioinformatics services. This acquisition is aimed at improving access to precision medicine testing and treatment.

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients